SmallCapReview (www.smallcapreview.com), a leading small-cap stock information site, is pleased to introduce Cryobanks International (OTC BB: BTEM) as a New ``Focus Stock'' to its database of subscribers and its website audience.
[ClickPress, Mon Mar 13 2006] Cryobanks International is a leader in the collection, processing and banking of umbilical cord blood stem cells. Cryobanks has a current cord blood bank inventory of over 8,500 units, plus over 1,000 research units.
The Company does not permit involvement in any research that is deemed controversial including cloning, embryonic, or cosmetic research. It is the mission of Cryobanks to ensure that anyone in need of a cord blood stem cell transplant will have a matched unit to access.
Cryobanks is an NMDP Bank accredited by the American Association of Blood Banks (AABB) in hematopoietic progenitor cell activities, licensed for tissue banking operations by the New York State Department of Health and registered with the Food and Drug Administration.
To learn more about Cryobanks please see the profile at www.smallcapreview.com/btem.htm or visit the company's website at www.cryo-intl.com
About SmallCapReview
SmallCapReview.com is a Free Newsletter sent to subscribers, highlighting select small-cap stocks, to register visit http://www.smallcapreview.com/subscribe.htm. Features available at SmallCapReview.com include in-depth profiles of select Small-Cap/Penny Stocks as well as the most comprehensive and up to date news available on the small-cap market.
Forward Looking Statements
Except for the historical information contained herein, the matters discussed in this release may include certain forward-looking statements, which are intended to be covered by safe harbors. Investors are cautioned that all forward-looking statements involve risks and uncertainties including, without limitation, the factors detailed from time to time in company filings with the Securities and Exchange Commission. These factors could affect businesses and financial results in the future and could cause actual results to differ materially from plans and projections. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as a representation by the company or any other person that objectives and plans will be achieved. All forward-looking statements made in this release are based on information presently available. We assume no obligation to update any forward-looking statements, except as required by law.
Disclosure: SmallCapReview.com is not a registered investment advisor or broker/dealer. No investor should assume that reliance on the views, opinions or recommendations contained herein will produce profitable results. Nothing within our site should be construed as an offer or solicitation to buy or sell products or securities. The companies we profile may lack an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. SmallCapReview.com may hold positions in securities mentioned herein, and may make purchases or sales in such securities featured on our website or within our reports. In order to be in full compliance with the Securities Act of 1933, Section 17(b), SmallCapReview.com will disclose in it's disclaimer, what, if any compensation was received for our efforts in researching, presenting and disseminating this information to our subscriber database and featuring the report on our website. Factors that could affect results, levels of activity, performance or achievements and cause them to materially differ from those contained in the forward-looking statements include the failure to complete the acquisition of Cryobanks, and other factors that can be found in BioStem's filings with the Securities and Exchange Commission SmallCapReview.com has been compensated eight thousand dollars by a third party (DC) for its efforts in presenting the Cryobanks International profile on its website and distributing it to its database of subscribers, this creates an inherent conflict of interest and readers are encouraged to view the full disclaimer at http://www.smallcapreview.com/btem.htm
[+] Global news distribution by ClickPress. To manage your News Alerts Subscription, click here. To reach News Alerts subscribers via an Enhanced Distribution, click here.
Del.icio.us
Digg
Furl
Blinklist
Reddit